| PCa | prostate cancer |
| PSA | prostate specific antigen |
| MS | mass spectrometry |
| AUC | area under the curve |
| MRI | magnetic resonance imaging |
| NMR | nuclear magnetic resonance |
| ELISA | enzyme-linked immunosorbent assay |
| DRE | digital rectal examination |
| HPLC | high-performance liquid chromatography |
| FA | formic acid |
| UV/VIS | ultraviolet–visible |
| HPRP | high-pH reversed-phase chromatography |
| LC–MS | liquid chromatography–mass spectrometry |
| HRM | high resolution mass spectrometry |
| DIA | data-independent acquisition |
| FDR | false discovery rate |
| ROC | receiver operating characteristic |
| HE | Hematoxylin–eosin |
| GS | Gleason score |
| EPV | events per predictor variable |
| PEDF | pigment epithelium-derived factor |
| HPX | hemopexin |
| CD99 | cluster of differentiation 99 |
| CANX | calnexin precursor |
| FCER2 | Fc fragment Of IgE receptor II |
| HRNR | hornerin |
| KRT13 | keratin 13 |
| CD44 | cluster of differentiation 44 |
| RNASE2 | ribonuclease A family member 2 |